On April 15, 2024, the United States Securities and Exchange Commission (SEC) addressed a letter to Sanjeev Redkar, President of Apollomics Inc., regarding the company's Registration Statement on Form F-3. The SEC reviewed Apollomics' response dated April 12, 2024, and requested further amendments to the registration statement, along with additional information. The SEC's inquiry specifically pointed out an inconsistency between the company's claim that all board members reside outside of China and the disclosure that two directors are based in mainland China. The SEC indicated that after reviewing Apollomics' forthcoming amendment and response, additional comments may follow. The SEC provided contact information for further questions, directing them to Daniel Crawford and Tim Buchmiller from the Division of Corporation Finance Office of Life Sciences.

On April 15, 2024, the United States Securities and Exchange Commission (SEC) addressed a letter to Sanjeev Redkar, President of Apollomics Inc., regarding the company's Registration Statement on Form F-3. The SEC reviewed Apollomics' response dated April 12, 2024, and requested further amendments to the registration statement, along with additional information. The SEC's inquiry specifically pointed out an inconsistency between the company's claim that all board members reside outside of China and the disclosure that two directors are based in mainland China. The SEC indicated that after reviewing Apollomics' forthcoming amendment and response, additional comments may follow. The SEC provided contact information for further questions, directing them to Daniel Crawford and Tim Buchmiller from the Division of Corporation Finance Office of Life Sciences.